NewEdge Advisors’s VivoSim Labs VIVS Stock Holding History

NewEdge Advisors’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8	Closed	-$125	–	3893
2023 Q3	$125	Sell	8 -9	-53%	-$159	﹤0.01%	3355
2023 Q2	$338	Sell	17 -16	-48%	-$361	﹤0.01%	3349
2023 Q1	$876	Sell	33 -1	-3%	-$24	﹤0.01%	3175
2022 Q4	$15	Buy	+34	New	+$680	﹤0.01%	3652

Other funds holding VIVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

NewEdge Advisors's VIVS Position: Q4 2023 in Review

NewEdge Advisors sold out of VivoSim Labs (VIVS) in Q4 2023, closing a stake of 8 shares — an estimated $125 sold.

NewEdge Advisors first reported a position in VIVS in Q4 2022 and held it in 4 quarters. The position peaked at $876 in Q1 2023. 33 funds tracked by Wall St. Rank hold VIVS as of Q4 2023.

NewEdge Advisors reported no remaining VivoSim Labs position as of Q4 2023 after selling out during the quarter.
NewEdge Advisors sold 8 VivoSim Labs shares in Q4 2023, an estimated $125.
NewEdge Advisors first reported a position in VivoSim Labs in Q4 2022 and held it in 4 quarters.
NewEdge Advisors's VivoSim Labs position peaked at $876 in Q1 2023.
33 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2023.

Based on NewEdge Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.